Trial Profile
A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs INO 3107 (Primary) ; INO 9012 (Primary)
- Indications Head and neck cancer; Human papillomavirus infections; Lung cancer; Squamous cell cancer
- Focus Adverse reactions
- Sponsors Inovio Pharmaceuticals
- 28 Apr 2020 Results presented at the 111th Annual Meeting of the American Association for Cancer Research - I
- 15 Oct 2018 Status changed from active, no longer recruiting to completed.
- 24 Jul 2018 Planned End Date changed from 1 Dec 2018 to 1 Sep 2018.